Diabetes Prevention in Clinical Practice. (DIAVIP)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2016 by Göteborg University
Information provided by (Responsible Party):
Göteborg University
ClinicalTrials.gov Identifier:
First received: April 15, 2013
Last updated: January 7, 2016
Last verified: January 2016
We randomize individuals with impaired glucose tolerance to one of three arms for degree of physical activity: 1. Continue with your current life style; 2. Ordinary life activities for increased physical activity; 3. Scheduled group activities for changed behavior. The overall aim is to focus on change of physical activity and to keep other life style activities more or less unchanged (diet, smoking, etc) and the effect on metabolic variables.

Condition Intervention
Type 2 Diabetes
Behavioral: Low intensity intervention
Behavioral: High intensity intervention.

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Diabetes Prevention in Primary Health Care With Special Emphasis on Physical Activity.

Further study details as provided by Göteborg University:

Primary Outcome Measures:
  • HOMA IR [ Time Frame: 12 months after inclusion (baseline) ] [ Designated as safety issue: No ]
    Insulin resistance according to HOMA

Estimated Enrollment: 2000
Study Start Date: June 2016
Estimated Study Completion Date: April 2020
Estimated Primary Completion Date: January 2020 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: No intervention
Experimental: Low intensity intervention Behavioral: Low intensity intervention
We administer, a pedometer and the participants receive a prescription on physical exercise.
Experimental: High intensity intervention Behavioral: High intensity intervention.
We schedule group sessions for changes in behavior e.g. type of physical activity to prefer, barriers for change of life style etc.


Ages Eligible for Study:   20 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Impaired glucose tolerance
  2. Age: 20-85yrs

Exclusion Criteria:

  1. Type2 diabetes
  2. Significant disease making life style changes unlikely to happen
  3. Unable to communicate in Swedish
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Göteborg University
ClinicalTrials.gov Identifier: NCT01834378     History of Changes
Other Study ID Numbers: DIAVIP-1204  Swedish Research Council 
Study First Received: April 15, 2013
Last Updated: January 7, 2016
Health Authority: Sweden: The National Board of Health and Welfare

Keywords provided by Göteborg University:
insulin resistance

ClinicalTrials.gov processed this record on May 26, 2016